Literature DB >> 23312987

Intensivists improve outcomes and compliance with process measures in critically ill patients.

Uroghupatei P Iyegha1, Javariah I Asghar, Elizabeth B Habermann, Alain Broccard, Craig Weinert, Greg Beilman.   

Abstract

BACKGROUND: Specialty-trained intensivist involvement in the care of critically ill patients has been associated with improved outcomes; however, the factors contributing to this observation are unknown. We hypothesized that intensivist-led ICU care would result in decreased mortality, length of stay, and rate of deep venous thrombosis/pulmonary embolism along with improved compliance with ICU process measures. STUDY
DESIGN: We performed a retrospective review of 847 patients using the October 2008 transition at a regional medical center from an open ICU to a model in which board-certified intensivists assume primary responsibility or co-management of all critically ill patients. Included in the analysis were patients admitted to the ICU during the 3 months immediately before the transition (June to September 2008) and a 3-month period 1 year later (June to September 2009). End points included mortality, length of stay, and deep venous thrombosis/pulmonary embolism rates, as well as several ICU process measures.
RESULTS: Patients in the post-intensivist cohort had a shorter hospital length of stay (7.4 days vs 8.7 days; p = 0.009) and a trend toward decreased mortality (9.3% vs 13.3%; p = 0.086). Patients also received timely initiation of deep venous thrombosis prophylaxis more frequently and tended toward more frequent timely initiation of nutritional support. Patients in the post-intensivist cohort admitted to the ICU with sepsis demonstrated a significant decrease in mortality (11.4% vs 35.0%, p = 0.010), both overall and in patients with APACHE II scores >20.
CONCLUSIONS: Intensivist-led ICU care is associated with improved outcomes in patients with sepsis and possibly in all ICU patients. Compliance with selected evidence-based practices improved. Additional study is needed to understand the mechanisms by which the intensivist model improves outcomes.
Copyright © 2013 American College of Surgeons. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23312987     DOI: 10.1016/j.jamcollsurg.2012.11.008

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  6 in total

Review 1.  ICU director data: using data to assess value, inform local change, and relate to the external world.

Authors:  David J Murphy; Ogbonna C Ogbu; Craig M Coopersmith
Journal:  Chest       Date:  2015-04       Impact factor: 9.410

2.  The future workforce of our Intensive Care Units - Doctor, physician assistant or no-one?

Authors:  Owen Boyd; Lynn Evans
Journal:  J Intensive Care Soc       Date:  2016-07-25

3.  Mortality Among Older Adults Before Versus After Hospital Transition to Intensivist Staffing.

Authors:  Myura Nagendran; Justin B Dimick; Andrew A Gonzalez; John D Birkmeyer; Amir A Ghaferi
Journal:  Med Care       Date:  2016-01       Impact factor: 2.983

4.  Paradigm shifts in critical care medicine: the progress we have made.

Authors:  Jean-Louis Vincent; Jacques Creteur
Journal:  Crit Care       Date:  2015-12-18       Impact factor: 9.097

5.  Mortality rate and other clinical features observed in Open vs closed format intensive care units: A systematic review and meta-analysis.

Authors:  Qian Yang; Jin Long Du; Feng Shao
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

Review 6.  Early goal-directed therapy in severe sepsis and septic shock: insights and comparisons to ProCESS, ProMISe, and ARISE.

Authors:  H Bryant Nguyen; Anja Kathrin Jaehne; Namita Jayaprakash; Matthew W Semler; Sara Hegab; Angel Coz Yataco; Geneva Tatem; Dhafer Salem; Steven Moore; Kamran Boka; Jasreen Kaur Gill; Jayna Gardner-Gray; Jacqueline Pflaum; Juan Pablo Domecq; Gina Hurst; Justin B Belsky; Raymond Fowkes; Ronald B Elkin; Steven Q Simpson; Jay L Falk; Daniel J Singer; Emanuel P Rivers
Journal:  Crit Care       Date:  2016-07-01       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.